Tradestie Institutional Equity Comparison Engine
CASI vs STTK โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
STTK Overall Edge
STTK Captures Institutional Edge (3โ0 Pillars ยท 7โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Shattuck Labs, Inc. Common Stock (STTK) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, CASI trades at N/M Forward P/E with -333.1% operating margin (-60.5% YoY revenue) versus STTK at N/M Forward P/E and 0.0% operating margin (-66.6% YoY). In options structure, CASI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against STTK sits in BREAKDOWN (10th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
CASI N/M vs STTK N/M Fwd P/E
Growth & Margin Winner
STTK
Op Margin -333.1% vs 0.0% ยท YoY -60.5% vs -66.6%
Momentum & Technical Winner
STTK
1Y -91.4% vs +127.5% ยท 52W Pos 0% vs 40%
Options & Structure Winner
STTK
UNCLASSIFIED (N/A IV) vs BREAKDOWN (10th %ile IV)
CASI
NASDAQ
CASI Pharmaceuticals, Inc. Ordinary Shares
Pharmaceutical Preparations
$0.21
-74.06% 1D
Market Cap
$12.4M
1M Return
-78.83%
1Y Return
-91.43%
Forward P/E
N/M
Unified AI Score
44.7 / 100
HOLD
Tech 40.0
Fund 44.0
Flow 50.0
Mom 44.0
STTK
NASDAQ
Shattuck Labs, Inc. Common Stock
Pharmaceutical Preparations
$4.46
-1.98% 1D
Market Cap
$459.3M
1M Return
-20.36%
1Y Return
+127.55%
Forward P/E
N/M
Unified AI Score
61.7 / 100
BUY
Tech 78.0
Fund 69.0
Flow 63.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
CASI -91.43%
STTK +127.55%
Spread: +189.34 pp (STTK Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
CASI TTM Op. Margin: -333.1%
STTK TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CASI vs STTK. Trailing 12-month operating profitability (CASI -333.1% vs STTK 0.0%) and valuation multiples (CASI N/M vs STTK N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CASI | STTK | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $12.4M | $459.3M | Larger Scale | STTK |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -60.5% | -66.6% | Higher Growth | CASI |
| Operating Margin (TTM) Profitability | -333.1% | 0.0% | Higher Margin | STTK |
| Net Profit Margin Profitability | -184.0% | 0.0% | Higher Margin | STTK |
| Return on Equity (ROE) Capital Efficiency | -1094.5% | -47.2% | Higher ROE | STTK |
| 52-Week Range Position Momentum | 0% ($0โ$3) | 40% ($2โ$8) | Stronger Trend | STTK |
| Beta / 30D Volatility Risk Regime | 0.95ฮฒ ยท 240% Vol | 1.41ฮฒ ยท 68% Vol | Lower Realized Risk | STTK |
| Unified Institutional Score Composite Signal | 44.7 / 100 (HOLD) | 61.7 / 100 (BUY) | Higher Composite | STTK |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full CASI vs STTK Buy Guide
CASI
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
STTK
BREAKDOWN
62d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
10th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither CASI nor STTK registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.